British pharmaceutical giant AstraZeneca on Monday said net profit rose in its second quarter, driven once again by strong growth in sales of its cancer drugs.
READ ALSO: Singapore Tightens Monetary Policy As Iran War Drags
Profit after tax climbed more than two percent to $2.5 billion in the three months to the end of June, compared with the same period last year, AstraZeneca said in a results statement.
AFP
